The Journal of Allergy and Clinical Immunology
Volume 124, Issue 5 , Pages 928-932.e1 , November 2009

Diagnostic properties of inhaled mannitol in the diagnosis of asthma: A population study

Received 23 October 2008 ,Revised 19 June 2009 ,Accepted 23 June 2009.

References 

  1. Cockroft DW, Davis BE. Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol. 2006;118:551–559
  2. Schoor JV, Pauwels R, Joos G. Indirect bronchial hyper-responsiveness: the coming of age of a specific group of bronchial challenges. Clin Exp Allergy. 2005;35:250–261
  3. Global Initiative for Asthma. From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2007. Available at: http://www.ginasthma.org. Accessed February 2009.
  4. Brusasco V, Crimi E. Methacholine provocation test for diagnosis of allergic respiratory diseases. Allergy. 2001;56:1114–1120
  5. Kolnaar BGM, Folgering H, Hoogen HJM, van den, van Weel C. Asymptomatic bronchial hyperresponsiveness in adolescents and young adults. Eur Respir J. 1997;10:44–50
  6. Backer V, Ulrik CS. Bronchial responsiveness to exercise in a random sample of 494 children and adolescents from Copenhagen. Clin Exp Allergy. 1992;22:741–747
  7. de Meer G, Marks GB, Postma DS. Direct or indirect stimuli for bronchial challenge testing: what is the relevance for asthma epidemiology?. Clin Exp Allergy. 2004;34:9–16
  8. Anderson SD. Provocative challenges to help diagnose and monitor asthma: exercise, methacholine, adenosine and mannitol. Curr Opin Pulm Med. 2008;14:39–45
  9. Porsbjerg C, Brannan JD, Anderson SD, Backer V. Relationship between airway responsiveness to mannitol and to methacholine and markers of airway inflammation, peak flow variability and quality of life in asthma patients. Clin Exp Allergy. 2008;38:43–50
  10. Joos GF, O'Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlén B, et al. Indirect airway challenges. Eur Respir J. 2003;21:1050–1068
  11. Brannan JD, Koskela H, Anderson SD, Chan HL. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology. 2002;7:37–44
  12. Brannan JD, Koskela H, Anderson SD. Monitoring asthma therapy using indirect bronchial provocation tests. Clin Respir J. 2007;1:3–15
  13. Anderson SD, Brannan J, Spring J, Spalding N, Rodwell LT, Chan K, et al. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med. 1997;156:758–765
  14. Leuppi JD, Brannan JD, Anderson SD. Bronchial provocation tests: The rationale for using inhaled mannitol as a test for airway hyperresponsiveness. Swiss Med Wkly. 2002;132:151–158
  15. Winder JA, Nash K, Brunn JW. Validation of a life quality (LQ) test for asthma. Ann Allergy Asthma Immunol. 2000;85:467–472
  16. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161:309–329
  17. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338
  18. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–968
  19. Alberg AJ, Park JW, Hager BW, Brock MV, Diener-West M. The use of “overall accuracy” to evaluate the validity of screening or diagnostic tests. J Gen Intern Med. 2004;19:460–465
  20. Fowler SJ, Dempsey OJ, Sims EJ, Lipworth BJ. Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)-receptor genotype. Am J Respir Crit Care Med. 2000;162:1318–1322
  21. Macy E, Bernstein JA, Castells MC, Gawchik SM, Lee TH, Settipane RA, et al. Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol. 2007;98:172–174
  22. Thomsen SF, Ulrik CS, Larsen K, Backer V. Change in prevalence of asthma in Danish children and adolescents. Ann Allergy Asthma Immunol. 2004;92:506–511
  23. Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368:733–743
  24. Cockcroft DW, Murdock KY, Berscheid BA, Gore BP. Sensitivity and specificity of histamine PC20, determination in a random selection of young college students. J Allergy Clin Immunol. 1992;89:23–30
  25. Backer V, Groth S, Dirksen A, Bach-Mortensen N, Hansen KK, Laursen EM, et al. Sensitivity and specificity of the histamine challenge test for the diagnosis of asthma in an unselected sample of children and adolescents. Eur Respir J. 1991;4:1093–1100
  26. Nolte H, Nepper-Christiansen S, Backer V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med. 2006;100:354–362

 The Danish Agency for Science, Technology and Innovation, an institution under the Danish Ministry of Science, Technology and Innovation, granted a 1-year scholarship. Pharmaxis provided the research team with an unrestricted grant, with which one of the research assistants was employed. Moreover, parts of the Mannitol kits were delivered at no cost by Pharmaxis.

 Disclosure of potential conflict of interest: V. Backer has received research support from Pharmaxis. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(09)00984-1

doi: 10.1016/j.jaci.2009.06.028

The Journal of Allergy and Clinical Immunology
Volume 124, Issue 5 , Pages 928-932.e1 , November 2009

Article Tools

* Image Usage & Resolution